- Home
- LENZ vs CNDT Comparison
LENZ vs CNDT Comparison
Compare LENZ & CNDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- CNDT
- Stock Information
- Founded
- LENZ 2019
- CNDT 2016
- Country
- LENZ United States
- CNDT United States
- Employees
- LENZ N/A
- CNDT N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- CNDT Business Services
- Sector
- LENZ Health Care
- CNDT Consumer Discretionary
- Exchange
- LENZ Nasdaq
- CNDT Nasdaq
- Market Cap
- LENZ 614.9M
- CNDT 628.4M
- IPO Year
- LENZ 2021
- CNDT N/A
- Fundamental
- Price
- LENZ $23.82
- CNDT $4.11
- Analyst Decision
- LENZ Strong Buy
- CNDT Buy
- Analyst Count
- LENZ 6
- CNDT 1
- Target Price
- LENZ $35.40
- CNDT $9.00
- AVG Volume (30 Days)
- LENZ 197.6K
- CNDT 878.5K
- Earning Date
- LENZ 11-06-2024
- CNDT 02-12-2025
- Dividend Yield
- LENZ 30.67%
- CNDT N/A
- EPS Growth
- LENZ N/A
- CNDT N/A
- EPS
- LENZ N/A
- CNDT 2.20
- Revenue
- LENZ N/A
- CNDT $3,509,000,000.00
- Revenue This Year
- LENZ N/A
- CNDT N/A
- Revenue Next Year
- LENZ N/A
- CNDT N/A
- P/E Ratio
- LENZ N/A
- CNDT $1.87
- Revenue Growth
- LENZ N/A
- CNDT N/A
- 52 Week Low
- LENZ $2.57
- CNDT $2.96
- 52 Week High
- LENZ $38.93
- CNDT $4.59
- Technical
- Relative Strength Index (RSI)
- LENZ 35.08
- CNDT 53.52
- Support Level
- LENZ $21.34
- CNDT $3.74
- Resistance Level
- LENZ $23.84
- CNDT $4.17
- Average True Range (ATR)
- LENZ 1.58
- CNDT 0.14
- MACD
- LENZ -0.39
- CNDT 0.00
- Stochastic Oscillator
- LENZ 25.78
- CNDT 87.21
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.